Latest News

View All >>

Pre- and Post-Surgical Keytruda Boosts Outcomes in Early NSCLC

June 4th 2023

By Silas Inman

Adding Keytruda to pre-surgical chemotherapy then giving it again after surgery improved event-free survival and pathologic complete response in patients with early-stage lung cancer.

An App Improved Anxiety, Depression Symptoms in Patients With Cancer

June 3rd 2023

By Alex Biese

Participants in the RESTORE study, results of which were presented this weekend at ASCO, saw “significant improvements” in depression and anxiety symptoms after using the Attune app.

Imjudo-Imfinzi Regimen Improves Survival With Manageable Side Effects in Liver Cancer Subset

June 3rd 2023

By Lindsay Fischer

Patients with unresectable hepatocellular carcinoma treated with the STRIDE regimen, consisting of Imjudo and Imfinzi, experienced manageable immune-related side effects with improvements in overall survival.

Patients with HR+, HER2–, Early Breast Cancer Experienced Survival Improvement with Verzenio Plus Endocrine Therapy

June 3rd 2023

By Brittany Lovely

Findings from the monarchE trial presented at ASCO showed that for patients with hormone receptor–positive, HER2-negative, high-risk, early breast cancer, Verzenio provided “consistent treatment benefit.”

Radium-223 Safe and Effective to Treat Metastatic Castration-Resistant Prostate Cancer

June 3rd 2023

By Darlene Dobkowski, MA

Treating patients with metastatic castration-resistant prostate cancer with radium-223 also allowed patients to receive subsequent therapies such as chemotherapy.